Comparative Study
Naproxen and piroxicam. A comparative trial in rheumatoid arthritis
- PMID: 6239778
Item in Clipboard
Comparative Study
Naproxen and piroxicam. A comparative trial in rheumatoid arthritis
Eur J Rheumatol Inflamm.
1983.
Abstract
A single-blind crossover trial in 60 patients with rheumatoid arthritis showed that piroxicam, 20 mg daily and naproxen, 500 mg twice daily were comparable in both efficacy and tolerance.
Similar articles
-
Piroxicam versus naproxen in rheumatoid arthritis: a double-blind, cross-over study.Int J Clin Pharmacol Res. 1985;5(1):17-23. Int J Clin Pharmacol Res. 1985. PMID: 3888863 Clinical Trial.
-
Comparison of naproxen and piroxicam in the treatment of rheumatoid arthritis: a double-blind, crossover study.Pharmatherapeutica. 1985;4(2):113-21. Pharmatherapeutica. 1985. PMID: 3903778 Clinical Trial.
-
Double-blind evaluation of piroxicam and naproxen following missed dosage in patients with inflammatory arthritis.N Z Med J. 1985 Jun 26;98(781):490-2. N Z Med J. 1985. PMID: 3892383 Clinical Trial.
-
Isoxicam.Clin Rheum Dis. 1984 Aug;10(2):385-99. Clin Rheum Dis. 1984. PMID: 6391795 Review. No abstract available.
-
Practical therapeutics: the newer nonsteroidal anti-inflammatory drugs.East Afr Med J. 1982 Jun;59(6):366-73. East Afr Med J. 1982. PMID: 6756881 Review. No abstract available.
Cited by
-
Naproxen. A reappraisal of its pharmacology, and therapeutic use in rheumatic diseases and pain states.Drugs. 1990 Jul;40(1):91-137. doi: 10.2165/00003495-199040010-00006. Drugs. 1990. PMID: 2202585 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical